No new recall of Gilead COVID treatment
Bill Oxford         

Bloomberg issued a correction to its story noting a recall of two lots of Gilead Sciences (NASDAQ:GILD) COVID-19 therapy Veklury (remdesivir) has been completed and that ths story was based on an FDA statement in December.